ENTRESTO…
ALBENZA…
AFLURIA…
“Not again!”
No, I promise. I have
already written two posts on the inexplicable naming of prescription medicines
and, although the third time can be the charm, it can also be “I’m not reading
this anymore.”
Despite residual misgivings, I have come to terms with the
fact that these laughable prescription medicine names have a memorable, syllabically
meaningless objective.
JUBLIA
HARVONI
It is undeniable that the gibberish names the pharmaceutical
companies give their products are at least more memorable to the than their
generic or their actual chemical
names. That’s why they create them. Fine.
Except I still don’t understand why the prescription medicine called JUBLIA could not just as easily be called
HARVONI and the prescription
medicine called HARVONI could not just
as easily be called AFLURIA.
I mean what the heck difference would it make?
But forget about that, it’s done and it’s over. I am, however, left with an equally troubling
concern:
How do they come up
with the meaningless names they give to the medicines?
Why do I care about that?
What is my generic interest?
At first I thought simply, “It’s a funny thing, silly names
for prescription medicines.”
“Silly but helpful.”
Right. Because you
don’t want,
“I really need this medicine.”
“What’s it called?”
“‘Psyllosibo’… I
don’t remember.”
The goofy names seemed hilarious to me. Absurdity is always funny – write that down. So that’s why I wrote about it.
Or so I believed.
The intensity of my feelings, however, suggested there was a
deeper consideration. I felt viscerally
angry about these ridiculous medicine names.
Not primarily because they were ridiculous – “ridiculous” is good for
business.
I was angry because they were arbitrary.
Imagined Pharmaceutical Company “Pitch Session”:
“LYZINGA”
“No. But “ZYLINGA”. Now you’ve got something!”
What!?!
To provide the link between the dopey medicine names and my
irrational hostility to them, I need to explain that, in my “Imagined
Pharmaceutical Pitch Session”, “LYZINGA”
was pitched by a pharmaceutical company employee and “ZYLINGA” was suggested by the boss.
That’s what
annoyed me. Not “What it is.” But “Who gets to decide?”
What did that remind me of?
(This is like psychoanalysis… I imagine, having never experienced psychoanalysis
– “free association” till I get to the answer.)
What it reminded me of was every time I sat in a rewrite
room and I pitched something that the show runner shot down, only to pitch an
alternative that was no better and possibly worse but it got into the script
because the person who pitched it was indisputably in charge.
Boy, that made me
angry!
That gnawing inequity not
only was potentially damaging to the final product – meaning it made the show worse – it was essentially rewarding a
bully, which infuriated me, while dismissing the efforts of a now dispirited
underling, which infuriated me even more.
(Which led to my saying, “I would rather be a boss than have a
boss. Later, when I became a boss, I had a somewhat different perspective.)
That explains my
irateness about the pharmaceutical naming – not
the absurdity but the method of deciding. When the thing you are deciding upon is meaningless,
the final decision is entirely arbitrary.
And when it comes to “arbitrary”, “Power” inevitably
prevails.
Now you might be thinking,
“You know what, Earlo?
This sounds an awful lot like ‘sour grapes’. A person in charge, who is generally more
experienced and more talented than you are shoots down your suggestion and
replaces it with his (or her) own. It’s
been twenty or more years now. It might be time to get over it.”
Okay… maybe… I respond, in partial concession. But you have never been in a room where we are
pitching “character names” and you pitch the name “Susan” and the show runner
shrieks “Susan!” as if they cannot
now fathom the reason they hired you and are seriously considering letting you
go. They then pitch “Susanne”, which
goes immediately into the script.
And don’t get me started on “locations.”
“‘Buffalo!’ Are you kidding me? You might as well say ‘Cleveland!”
They pitch “Chicago”, and on we go.
“LYZINGA” – “ZYLINGA”?
It is exactly the same thing.
I was angry about that then, and I am angry about it now–
not for myself this time, but for the pharmaceutical company peons caught in a
similar dispiriting position.
Believe me, LYZINGA
is just as good as ZYLINGA.
And, having gotten to the source of my irritation, I shall not mention this matter again.
Most likely.